MD Anderson Cancer Center/University of Texas MD Anderson CC

Houston, Texas 77030

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Relapsed and Bortezomib Refractory Multiple Myeloma

Studies at this site

• Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma — Completed
• Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma — Completed